老年人中的城市质量和生物化学,血液学和营养标记:横截面的地理空间研究
Carlos Mena1, Yony Ormazabal1, Nacim Molina2
1Longevity Center VITALIS, Faculty of Economics and Business, University of Talca, Avenida Lircay S/N, Talca, Chile, Talca, Chile.
JMIR aging
|October 27, 2025
概括
城市质量显著影响老年人的脆弱性和代谢健康. 更好的城市环境与较高的脆弱性得分和较差的手握强度相关,尽管更接近医疗服务.
科学领域:
- 老年学是指老年学的学科.
- 城市卫生 城市卫生
- 公共卫生 公共卫生
背景情况:
- 城市环境通过诸如体育活动基础设施,社会/医疗支持和食物获取等因素显著影响脆弱性.
- 了解城市质量-脆弱性-代谢健康联系对于人口老龄化和公共卫生规划至关重要.
研究的目的:
- 使用地理空间分析量化城市领域对老年人脆弱性,营养状况和生物标志物的影响.
- 研究建筑环境,服务可访问性,绿色空间和社会经济背景与健康结果之间的关系.
主要方法:
- 研究了251名居住在社区的老年人 (年龄>65岁).
- 评估的脆弱性 (脆弱性特征量表5),营养状况 (控制营养状况得分) 和血液/生化参数.
- 使用GIS进行脆弱性的空间分析,绘制城市设施的地图并分析相关性.
主要成果:
- 脆弱性患病率为17.5%;脆弱的个体在城市质量较高的地区有更高的BMI和脆弱性得分.
- 弱者生活在靠近急诊医疗中心,家庭医疗中心和炼设施的地方.
- 在城市质量和胆红素,血清铁,转激素和,红细胞计数和RDWC以及营养状况得分之间发现了积极的相关性.
结论:
- 城市质量与血液学参数,营养状况和老年人的脆弱性有关.
- 较好的城市质量与较低的握力和较高的脆弱性得分有关,可能是由于医疗保健/娱乐机会增加.
- 城市规划应优先考虑适合老年人的环境,以减轻脆弱性和改善健康结果.
相关概念视频
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
227
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
227
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531